China’s CFDA Takes Steps to Improve Drug Review and Approval System
The Chinese Food and Drug Administration (CFDA) has come under heavy criticism for its slow and inefficient drug review and approval process, which has resulted in a backlog of 18,600 applications. To improve drug review processing, the CFDA recently recommended that pharmaceutical... Read More